HONORIO FREELAND: Open Payments
NPI 1659119915 · BROOMALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $671
Food & beverage: $587Education: $84
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $192 |
| ABBVIE INC. | 3 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $158 |
| Janssen Biotech, Inc. | 1 | $84 |
| QOL Medical, LLC | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
Products named: REZDIFFRA, RINVOQ, ENTYVIO, TREMFYA, SKYRIZI, Sucraid, GATTEX, XIFAXAN.
Industry payments across PA — which companies pay providers there.
